Abiopharma

News list

Clary Rebecca 🟡 adjusted position in 5.5K shares of Globalstar, Inc. (GSAT) at $79.85 Transaction Date: Apr 14, 2026 | Filing ID: 000007

Full text

News bot April 15, 2026, 9:27 p.m.
🔍 Clary Rebecca (Executive)

Company: Globalstar, Inc. (GSAT)

Report Date: 2026-04-14
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 9,524
- Total shares sold: 4,037
Detailed Transactions and Holdings:
- Acquired 9,524 shares of Voting Common Stock (Direct)
  Date: 2026-04-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 119,778.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 4,037 shares of Voting Common Stock at $79.85 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 115,741.00 | transaction_form_type: 4 | Footnotes: F2, F3
Footnotes:
- F1: Represents shares earned upon the vesting of a portion of a performance share award granted on March 27, 2025.
- F2: Shares sold to cover taxes due upon the vesting of a performance share award in accordance with a mandatory sell-to-cover program maintained by the registrant.
- F3: The shares were sold in multiple transactions at prices ranging from $79.7100 to $80.0800 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.